AKZO NOBEL N.V. (AKZA.AS) Fundamental Analysis & Valuation

AMS:AKZA • NL0013267909

Current stock price

49.12 EUR
-2.02 (-3.95%)
Last:

This AKZA.AS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. AKZA.AS Profitability Analysis

1.1 Basic Checks

  • In the past year AKZA was profitable.
  • AKZA had a positive operating cash flow in the past year.
  • Each year in the past 5 years AKZA has been profitable.
  • Each year in the past 5 years AKZA had a positive operating cash flow.
AKZA.AS Yearly Net Income VS EBIT VS OCF VS FCFAKZA.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

1.2 Ratios

  • AKZA has a Return On Assets of 4.55%. This is in the better half of the industry: AKZA outperforms 62.86% of its industry peers.
  • The Return On Equity of AKZA (13.63%) is better than 74.29% of its industry peers.
  • AKZA's Return On Invested Capital of 8.24% is fine compared to the rest of the industry. AKZA outperforms 70.00% of its industry peers.
Industry RankSector Rank
ROA 4.55%
ROE 13.63%
ROIC 8.24%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AKZA.AS Yearly ROA, ROE, ROICAKZA.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

1.3 Margins

  • AKZA has a better Profit Margin (6.25%) than 64.29% of its industry peers.
  • In the last couple of years the Profit Margin of AKZA has declined.
  • AKZA has a Operating Margin of 11.46%. This is in the better half of the industry: AKZA outperforms 70.00% of its industry peers.
  • AKZA's Operating Margin has been stable in the last couple of years.
  • With a Gross Margin value of 39.86%, AKZA perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
  • AKZA's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 11.46%
PM (TTM) 6.25%
GM 39.86%
OM growth 3Y20.63%
OM growth 5Y0.3%
PM growth 3Y24.42%
PM growth 5Y-3.28%
GM growth 3Y3.29%
GM growth 5Y-2.12%
AKZA.AS Yearly Profit, Operating, Gross MarginsAKZA.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. AKZA.AS Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so AKZA is still creating some value.
  • There is no outstanding debt for AKZA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
AKZA.AS Yearly Shares OutstandingAKZA.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
AKZA.AS Yearly Total Debt VS Total AssetsAKZA.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • An Altman-Z score of 2.27 indicates that AKZA is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 2.27, AKZA perfoms like the industry average, outperforming 51.43% of the companies in the same industry.
  • AKZA has a debt to FCF ratio of 8.04. This is a slightly negative value and a sign of low solvency as AKZA would need 8.04 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 8.04, AKZA perfoms like the industry average, outperforming 51.43% of the companies in the same industry.
  • AKZA has a Debt/Equity ratio of 0.79. This is a neutral value indicating AKZA is somewhat dependend on debt financing.
  • AKZA has a worse Debt to Equity ratio (0.79) than 74.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.79
Debt/FCF 8.04
Altman-Z 2.27
ROIC/WACC1.24
WACC6.67%
AKZA.AS Yearly LT Debt VS Equity VS FCFAKZA.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B 10B

2.3 Liquidity

  • AKZA has a Current Ratio of 1.44. This is a normal value and indicates that AKZA is financially healthy and should not expect problems in meeting its short term obligations.
  • AKZA has a worse Current ratio (1.44) than 61.43% of its industry peers.
  • AKZA has a Quick Ratio of 1.08. This is a normal value and indicates that AKZA is financially healthy and should not expect problems in meeting its short term obligations.
  • AKZA has a Quick ratio of 1.08. This is comparable to the rest of the industry: AKZA outperforms 47.14% of its industry peers.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 1.08
AKZA.AS Yearly Current Assets VS Current LiabilitesAKZA.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. AKZA.AS Growth Analysis

3.1 Past

  • AKZA shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -6.43%.
  • AKZA shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -1.32% yearly.
  • AKZA shows a decrease in Revenue. In the last year, the revenue decreased by -5.16%.
  • Measured over the past years, AKZA shows a small growth in Revenue. The Revenue has been growing by 3.56% on average per year.
EPS 1Y (TTM)-6.43%
EPS 3Y14.42%
EPS 5Y-1.32%
EPS Q2Q%0%
Revenue 1Y (TTM)-5.16%
Revenue growth 3Y-2.16%
Revenue growth 5Y3.56%
Sales Q2Q%-9.43%

3.2 Future

  • The Earnings Per Share is expected to grow by 14.14% on average over the next years. This is quite good.
  • AKZA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.43% yearly.
EPS Next Y15.8%
EPS Next 2Y13.09%
EPS Next 3Y10.75%
EPS Next 5Y14.14%
Revenue Next Year-2.92%
Revenue Next 2Y-0.21%
Revenue Next 3Y1.7%
Revenue Next 5Y6.43%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AKZA.AS Yearly Revenue VS EstimatesAKZA.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B
AKZA.AS Yearly EPS VS EstimatesAKZA.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. AKZA.AS Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 13.49, the valuation of AKZA can be described as correct.
  • Compared to the rest of the industry, the Price/Earnings ratio of AKZA indicates a somewhat cheap valuation: AKZA is cheaper than 74.29% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of AKZA to the average of the S&P500 Index (25.79), we can say AKZA is valued slightly cheaper.
  • Based on the Price/Forward Earnings ratio of 11.65, the valuation of AKZA can be described as reasonable.
  • 82.86% of the companies in the same industry are more expensive than AKZA, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 23.80. AKZA is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 13.49
Fwd PE 11.65
AKZA.AS Price Earnings VS Forward Price EarningsAKZA.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 68.57% of the companies in the same industry are more expensive than AKZA, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, AKZA is valued a bit cheaper than the industry average as 78.57% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 13.89
EV/EBITDA 7.38
AKZA.AS Per share dataAKZA.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • AKZA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.85
PEG (5Y)N/A
EPS Next 2Y13.09%
EPS Next 3Y10.75%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. AKZA.AS Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 3.78%, AKZA has a reasonable but not impressive dividend return.
  • AKZA's Dividend Yield is a higher than the industry average which is at 2.38.
  • AKZA's Dividend Yield is rather good when compared to the S&P500 average which is at 1.91.
Industry RankSector Rank
Dividend Yield 3.78%

5.2 History

  • The dividend of AKZA decreases each year by -21.52%.
Dividend Growth(5Y)-21.52%
Div Incr Years0
Div Non Decr Years4
AKZA.AS Yearly Dividends per shareAKZA.AS Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6

5.3 Sustainability

  • 60.16% of the earnings are spent on dividend by AKZA. This is not a sustainable payout ratio.
DP60.16%
EPS Next 2Y13.09%
EPS Next 3Y10.75%
AKZA.AS Yearly Income VS Free CF VS DividendAKZA.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B
AKZA.AS Dividend Payout.AKZA.AS Dividend Payout, showing the Payout Ratio.AKZA.AS Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

AKZA.AS Fundamentals: All Metrics, Ratios and Statistics

AKZO NOBEL N.V.

AMS:AKZA (3/19/2026, 9:54:20 AM)

49.12

-2.02 (-3.95%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-03
Earnings (Next)04-21
Inst Owners89.53%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap8.40B
Revenue(TTM)10.16B
Net Income(TTM)635.00M
Analysts77.6
Price Target69.17 (40.82%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.78%
Yearly Dividend1.98
Dividend Growth(5Y)-21.52%
DP60.16%
Div Incr Years0
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-20.39%
Min EPS beat(2)-33.37%
Max EPS beat(2)-7.4%
EPS beat(4)0
Avg EPS beat(4)-12.83%
Min EPS beat(4)-33.37%
Max EPS beat(4)-4.18%
EPS beat(8)1
Avg EPS beat(8)-7.59%
EPS beat(12)2
Avg EPS beat(12)-8.15%
EPS beat(16)3
Avg EPS beat(16)-13.47%
Revenue beat(2)0
Avg Revenue beat(2)-2.49%
Min Revenue beat(2)-4.05%
Max Revenue beat(2)-0.93%
Revenue beat(4)0
Avg Revenue beat(4)-3.08%
Min Revenue beat(4)-5.13%
Max Revenue beat(4)-0.93%
Revenue beat(8)1
Avg Revenue beat(8)-1.97%
Revenue beat(12)3
Avg Revenue beat(12)-1.59%
Revenue beat(16)3
Avg Revenue beat(16)-1.66%
PT rev (1m)-1.09%
PT rev (3m)-1.18%
EPS NQ rev (1m)-5.4%
EPS NQ rev (3m)-15.34%
EPS NY rev (1m)-3.9%
EPS NY rev (3m)-7.49%
Revenue NQ rev (1m)-1.17%
Revenue NQ rev (3m)-7.96%
Revenue NY rev (1m)-2.54%
Revenue NY rev (3m)-2.94%
Valuation
Industry RankSector Rank
PE 13.49
Fwd PE 11.65
P/S 0.83
P/FCF 13.89
P/OCF 9.19
P/B 1.8
P/tB 9.76
EV/EBITDA 7.38
EPS(TTM)3.64
EY7.41%
EPS(NY)4.22
Fwd EY8.58%
FCF(TTM)3.54
FCFY7.2%
OCF(TTM)5.34
OCFY10.88%
SpS59.39
BVpS27.24
TBVpS5.03
PEG (NY)0.85
PEG (5Y)N/A
Graham Number47.23
Profitability
Industry RankSector Rank
ROA 4.55%
ROE 13.63%
ROCE 11.94%
ROIC 8.24%
ROICexc 10.26%
ROICexgc 19.94%
OM 11.46%
PM (TTM) 6.25%
GM 39.86%
FCFM 5.96%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y20.63%
OM growth 5Y0.3%
PM growth 3Y24.42%
PM growth 5Y-3.28%
GM growth 3Y3.29%
GM growth 5Y-2.12%
F-Score5
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.79
Debt/FCF 8.04
Debt/EBITDA 2.38
Cap/Depr 81.75%
Cap/Sales 3.04%
Interest Coverage 7.19
Cash Conversion 59.27%
Profit Quality 95.28%
Current Ratio 1.44
Quick Ratio 1.08
Altman-Z 2.27
F-Score5
WACC6.67%
ROIC/WACC1.24
Cap/Depr(3y)81.45%
Cap/Depr(5y)81.15%
Cap/Sales(3y)2.86%
Cap/Sales(5y)2.86%
Profit Quality(3y)116.92%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-6.43%
EPS 3Y14.42%
EPS 5Y-1.32%
EPS Q2Q%0%
EPS Next Y15.8%
EPS Next 2Y13.09%
EPS Next 3Y10.75%
EPS Next 5Y14.14%
Revenue 1Y (TTM)-5.16%
Revenue growth 3Y-2.16%
Revenue growth 5Y3.56%
Sales Q2Q%-9.43%
Revenue Next Year-2.92%
Revenue Next 2Y-0.21%
Revenue Next 3Y1.7%
Revenue Next 5Y6.43%
EBIT growth 1Y26.94%
EBIT growth 3Y18.02%
EBIT growth 5Y3.86%
EBIT Next Year33.57%
EBIT Next 3Y15.49%
EBIT Next 5Y23.47%
FCF growth 1Y67.13%
FCF growth 3YN/A
FCF growth 5Y-8.8%
OCF growth 1Y36.83%
OCF growth 3Y53.24%
OCF growth 5Y-5.57%

AKZO NOBEL N.V. / AKZA.AS Fundamental Analysis FAQ

What is the ChartMill fundamental rating of AKZO NOBEL N.V. (AKZA.AS) stock?

ChartMill assigns a fundamental rating of 4 / 10 to AKZA.AS.


What is the valuation status for AKZA stock?

ChartMill assigns a valuation rating of 5 / 10 to AKZO NOBEL N.V. (AKZA.AS). This can be considered as Fairly Valued.


What is the profitability of AKZA stock?

AKZO NOBEL N.V. (AKZA.AS) has a profitability rating of 5 / 10.


What is the financial health of AKZO NOBEL N.V. (AKZA.AS) stock?

The financial health rating of AKZO NOBEL N.V. (AKZA.AS) is 3 / 10.


What is the earnings growth outlook for AKZO NOBEL N.V.?

The Earnings per Share (EPS) of AKZO NOBEL N.V. (AKZA.AS) is expected to grow by 15.8% in the next year.